التداخل بين أرغاتروبان وبنتوكسيفيلين

DRUG INTERACTIONS Bleeding has been reported in patients treated with pentoxifylline extended-release tablets with or without concomitant NSAIDs, anticoagulants, or platelet aggregation inhibitors.

Monitoring of anticoagulant activity in these patients is recommended when pentoxifylline is introduced or the dose is changed.

Postmarketing cases of increased anticoagulant activity have been reported in patients concomitantly treated with pentoxifylline and vitamin K antagonists.